Management of ovarian cysts

Slides:



Advertisements
Similar presentations
Dr. Mashael Al-Shebaili Asst. Prof. & Consultant Ob/Gyn Dept.
Advertisements

Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
MALIGNANT OVARIAN TUMOUR
بسم الله الرحمن الرحيم. Pelvic mass Dr.T Allameh MD.
Female Genitalia IV Ovary. l Inflammation l Non-neoplastic cysts l Neoplasms.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
Pelvic Pain Mr James Campbell.
TEMPLATE DESIGN © Premenopausal women presenting with high level tumour marker CA-125 and pelvic mass is not necessarily.
Renal Tumours n Mr C Dawson MS FRCS n Consultant Urologist n Fitzwilliam Hospital n Peterborough.
Diseases of the ovary Prof. Dr. Noorhan Shakir.
Ovarian Cancer Gloria S. Huang, M.D. Assistant Professor Department of Obstetrics & Gynecology and Women ’ s Health Division of Gynecologic Oncology Albert.
In The Nam of God.
OVARY 2 Neoplasms of the Ovary
Ovarian Cystic Masses Atoosa Adibi MD. Department of radiology
Malignant Ovarian Tumors
Ovary.
Ovarian cancer….. in 15 minutes
Breast Imaging Made Brief and Simple
Ovarian tumours.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Focus on Ovarian Cancer (Relates to Chapter 54, “Nursing Management: Female Reproductive Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc.,
Ovarian cysts in Primary Care. When to refer? Physiological/pathological Benign/malignant Surgical approach? Open or keyhole? Do I need to do anything?
Management of Adenxal Mass during Pregnancy
Approach to the Patient with a Pelvic Mass Karen Carlson, MD Assistant Professor Department of Obstetrics and Gynecology.
Gynaecological Causes of Acute Pelvic Pain Max Brinsmead MB BS PhD May 2015.
SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG
Department of pathology Prof:- Adiga. Student name :- Saeed Ayed saed Abdulrahman Awagi Alnami Muhannad Ali Asiri Faris.
Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Dr Matt Hewitt Prophylactic Bilateral Salpingoophorectomy.
Ovarian tumor Wei Jiang, M.D., Ph.D. Attending of Ob & Gyn Ob & Gyn Hospital, Fudan University 419 Fangxie Road, Shanghai -----From.
Ovarian Tumours Max Brinsmead MBBS PhD November 2014.
UOG Journal Club: January 2013
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
OVARIAN CANCER New NICE guidelines and the research behind them Journal Club 20/5/11 Natalie Brown and Matthew Parkes.
Ovarian Pathology for Undergraduates Max Brinsmead MB BS PhD November 2014.
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
TEMPLATE DESIGN © Primary Peritoneal Carcinoma found at caeserean section, value of routine abdominal examination at caeserean.
IRIA 67th Annual Conference
Ovarian Cancer Tumour Markers Brig Dilshad Ahmed Khan MBBS, MCPS, FCPS, FRC Path, PhD Head of Chem Pathology & Endocrinology dept AFIP, Rawalpindi.
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Dermoid Cyst of Ovary Brian Lee March 2013 Dr. Joy Sclamberg.
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
Ovarian Tumors By Dr. Ghada Ahmed Lecturer of pathology Benha Faculty of Medicine.
WANDERING OVARY DR. J.CHITRA M.D, DGO, D.NB ASST PROFESSOR KANYAKUMARI GOVT MEDICAL COLLEGE.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Ovarian Cancers In Pregnancy. Incidence Effect on Pregnancy Histologic Variations Clinical Variation Ovarian Cancers in Pregnancy.
Tamoxifen associated changes
Pregnancy related Breast Lesions
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Consultant Obstetrician & Gynaecologist
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Renal tumor.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Sonography and Ovarian Tumors Professor Galal Lotfi Obstetrics & Gynecology Suez Canal University. Egypt.
Sonography of ovarian masses Dr. Mohammed Abdalla Egypt, Domiat General Hospital.
Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist
Screening for Ovarian Cancer
Ovarian cysts and neoplasms in infant , children and adolescents
Benign and Malignant cysts and tumors of the ovary
COMPARISON OF RISK OF MALIGNANCY INDICES AND ASSESSMENT OF DIFFERENT NEOPLASIAS IN THE ADNEXA (ADNEX) MODEL AS PREOPERATIVE MALİGNANCY EVALUATION METHODS.
Dr . Saadeh Jaber OBGYN consultant 2010
Screening for Ovarian Cancer
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Ultrasonographic Imaging of Ovarian Masses
Ovarian tumors Ali Al Khader, M.D. Faculty of Medicine
Ovarian Cancer-Route to Diagnosis
Presentation transcript:

Management of ovarian cysts Dr Matt Hewitt

Ovarian cysts Benign Malignant Non ovarian e.g functional cysts, serous cystademonas, dermoid (teratoma) Malignant Epithelial tumours 90% - e.g serous cystadenoacrcinomas Sex cord tumours Germ cell tumours Metastatic Non ovarian e.g Hydrosalpinx, tubovarian abcess

Ovarian cancer Lifetime risk 1 in 70 90% are epithelial tumours 75% present at late stage III/IV 5 – 10 % Hereditary predisposition BRCA I and II HNPCC

Stage at diagnosis and 5 year survival FIGO Staging Uterus Cervix Ovary FIGO Staging

Pre menopausal ovarian cysts 10% of women will undergo ovarian surgery at some point Symptomatic cysts 1 to 3 1000 population Simple cysts < 5cm usually resolve, do not require follow up PCO on scan do not require follow up scan

Post menopausal cysts Increasing detection of ovarian cysts 21% have abnormal ovarian pathology Simple Cysts <5cm – low risk of malignancy

Clinical examination If its palpable it needs surgery Ascites Tenderness Fixed Differentiating between uterus and ovarian mass

Imaging Ultrasound good assessment of the ovary and presence of ascites MRI good but expensive assessment of ovary Rarely gives additional information on nature of cyst Is good in CT scan – not good at evaluating cyst - good in presence of ascites

Ultrasound Trans abdominal and transvaginal (TVS) Size Simple – unilocular, no blood flow Complex – Multilocular, solid elements, irregular, papillary projections, blood low Ascites

Tumour markers Ca 125 not sensitive and not specific Should not be used in assessment of abdominal pain hCG, α-FP, LDH Should not routinely be used Secondary care assessment germ cell tumours

Surgical management Laparoscopy – up to 12cm Laparotomy Cystectomy – if confident not malignant Unilateral oophorectomy Bilateral oophorectomy

WHO Principles of Screening Diagnostic test sensitive and specific simple and cheap safe and acceptable reliable Disease serious high prevalence of preclinical stage natural history understood lead time bias, length bias Diagnosis & Treatment facilities are adequate effective, acceptable, safe treatment available

Premenopausal Asymptomatic Ovarian cyst Simple <5cm No FU 5-7cm Rescan 3/12 >7cm Refer Complex <3cm 3-5cm Re scan 3/12 >5cm Premenopausal Asymptomatic

Post Menopausal Asymptomatic Ovarian cyst Simple <3cm Re scan 3/12 >5cm Refer Complex Re scan 3/12 >3cm With ascites Urgent Referal Post Menopausal Asymptomatic

Thank you